NASDAQ: RNA
Avidity Biosciences Inc Stock Ownership - Who owns Avidity Biosciences?

Insider buying vs selling

Have Avidity Biosciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
W. Michael FlanaganChief Scientific Officer2025-09-1120,000$14.22
$284.40kBuy
W. Michael FlanaganChief Scientific Officer2025-09-1120,000$38.94
$778.70kSell
Troy Edward WilsonDirector2025-09-0514,500$50.00
$725.00kSell
Troy Edward WilsonDirector2025-09-0514,500$12.48
$180.96kBuy
Sarah BoycePresident and CEO2025-09-0550,000$1.24
$62.00kBuy
Sarah BoycePresident and CEO2025-09-0550,000$49.95
$2.50MSell
Troy Edward WilsonDirector2025-09-0515,000$50.00
$750.00kSell
Eric MosbrookerChief Commercial Officer2025-09-036,563$47.07
$308.93kSell
Eric MosbrookerChief Commercial Officer2025-09-036,563$9.05
$59.40kBuy
Kathleen P. GallagherChief Program Officer2025-09-02188$47.42
$8.91kSell

1 of 12

RNA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RNA insiders and whales buy or sell their stock.

RNA Shareholders

What type of owners hold Avidity Biosciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Fmr LLC13.43%16,185,791$724.15MInstitution
Price T Rowe Associates Inc8.97%10,808,727$483.58MInstitution
Janus Henderson Group PLC8.94%10,777,317$482.18MInstitution
Rtw Investments LP7.98%9,618,845$430.35MInstitution
Blackrock Inc7.75%9,336,834$417.73MInstitution
Wellington Management Group LLP7.67%9,249,690$413.83MInstitution
Vanguard Group Inc7.67%9,248,302$413.77MInstitution
Rtw Investments LP7.29%8,790,000$393.26MInsider
Ra Capital Management LP6.03%7,266,031$325.08MInstitution
Avoro Capital Advisors LLC5.85%7,050,000$315.42MInstitution

1 of 3

RNA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RNA88.73%11.27%Net SellingNet Selling
ABVX48.35%0.00%
MRUS90.68%9.32%Net BuyingNet Buying
CRSP67.79%32.21%Net BuyingNet Buying
TGTX56.44%43.56%Net SellingNet Selling

Avidity Biosciences Stock Ownership FAQ

Who owns Avidity Biosciences?

Avidity Biosciences (NASDAQ: RNA) is owned by 112.81% institutional shareholders, 14.33% Avidity Biosciences insiders, and 0.00% retail investors. Rtw Investments LP is the largest individual Avidity Biosciences shareholder, owning 8.79M shares representing 7.29% of the company. Rtw Investments LP's Avidity Biosciences shares are currently valued at $393.26M.

If you're new to stock investing, here's how to buy Avidity Biosciences stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.